Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
Meleveedu KS, Miskovsky J, Meharg J, Abdelrahman A, Tandon R, Moody AE, Dasilva P, Masse G, LaPorte J, Saied Calvino A, Allen G, El-Bizri R, Roberts T, Armenio V, Katz SC.
Meleveedu KS, et al. Among authors: el bizri r.
Cytokine X. 2020 Dec;2(4):100035. doi: 10.1016/j.cytox.2020.100035. Epub 2020 Sep 2.
Cytokine X. 2020.
PMID: 32895645
Free PMC article.